189 related articles for article (PubMed ID: 32902381)
1. Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones.
Sarthy JF; Meers MP; Janssens DH; Henikoff JG; Feldman H; Paddison PJ; Lockwood CM; Vitanza NA; Olson JM; Ahmad K; Henikoff S
Elife; 2020 Sep; 9():. PubMed ID: 32902381
[TBL] [Abstract][Full Text] [Related]
2. H3F3A K27M Mutations Drives a Repressive Transcriptome by Modulating Chromatin Accessibility, Independent of H3K27me3 in Diffuse Midline Glioma.
Bhattarai S; Hakkim FL; Day CA; Grigore F; Langfald A; Entin I; Hinchcliffe EH; Robinson JP
bioRxiv; 2024 May; ():. PubMed ID: 38798502
[TBL] [Abstract][Full Text] [Related]
3. Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma.
Ocasio JK; Budd KM; Roach JT; Andrews JM; Baker SJ
Cancer Metastasis Rev; 2023 Jun; 42(2):367-388. PubMed ID: 37119408
[TBL] [Abstract][Full Text] [Related]
4. Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas.
Mota M; Sweha SR; Pun M; Natarajan SK; Ding Y; Chung C; Hawes D; Yang F; Judkins AR; Samajdar S; Cao X; Xiao L; Parolia A; Chinnaiyan AM; Venneti S
Proc Natl Acad Sci U S A; 2023 May; 120(18):e2221175120. PubMed ID: 37094128
[TBL] [Abstract][Full Text] [Related]
5. Histone H3.3 K27M and K36M mutations de-repress transposable elements through perturbation of antagonistic chromatin marks.
Chaouch A; Berlandi J; Chen CCL; Frey F; Badini S; Harutyunyan AS; Chen X; Krug B; Hébert S; Jeibmann A; Lu C; Kleinman CL; Hasselblatt M; Lasko P; Shirinian M; Jabado N
Mol Cell; 2021 Dec; 81(23):4876-4890.e7. PubMed ID: 34739871
[TBL] [Abstract][Full Text] [Related]
6. Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma.
Sharma M; Barravecchia I; Magnuson B; Ferris SF; Apfelbaum A; Mbah NE; Cruz J; Krishnamoorthy V; Teis R; Kauss M; Koschmann C; Lyssiotis CA; Ljungman M; Galban S
Neoplasia; 2023 Oct; 44():100931. PubMed ID: 37647805
[TBL] [Abstract][Full Text] [Related]
7. A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell-of-origin dependent effects of H3K27M.
Tomita Y; Shimazu Y; Somasundaram A; Tanaka Y; Takata N; Ishi Y; Gadd S; Hashizume R; Angione A; Pinero G; Hambardzumyan D; Brat DJ; Hoeman CM; Becher OJ
Glia; 2022 Sep; 70(9):1681-1698. PubMed ID: 35524725
[TBL] [Abstract][Full Text] [Related]
8. Reduced histone gene copy number disrupts Drosophila Polycomb function.
McPherson JE; Grossmann LC; Salzler HR; Armstrong RL; Kwon E; Matera AG; McKay DJ; Duronio RJ
Genetics; 2023 Aug; 224(4):. PubMed ID: 37279945
[TBL] [Abstract][Full Text] [Related]
9. Identification of a differentiation stall in epithelial mesenchymal transition in histone H3-mutant diffuse midline glioma.
Sanders LM; Cheney A; Seninge L; van den Bout A; Chen M; Beale HC; Kephart ET; Pfeil J; Learned K; Lyle AG; Bjork I; Haussler D; Salama SR; Vaske OM
Gigascience; 2020 Dec; 9(12):. PubMed ID: 33319914
[TBL] [Abstract][Full Text] [Related]
10. H2A.Z histone variants facilitate HDACi-dependent removal of H3.3K27M mutant protein in pediatric high-grade glioma cells.
Leszczynska KB; Freitas-Huhtamäki A; Jayaprakash C; Dzwigonska M; Vitorino FNL; Horth C; Wojnicki K; Gielniewski B; Szadkowska P; Kaza B; Nazarian J; Ciolkowski MK; Trubicka J; Grajkowska W; Garcia BA; Majewski J; Kaminska B; Mieczkowski J
Cell Rep; 2024 Feb; 43(2):113707. PubMed ID: 38306270
[TBL] [Abstract][Full Text] [Related]
11. Coordinate redeployment of PRC1 proteins suppresses tumor formation during Drosophila development.
Loubière V; Delest A; Thomas A; Bonev B; Schuettengruber B; Sati S; Martinez AM; Cavalli G
Nat Genet; 2016 Nov; 48(11):1436-1442. PubMed ID: 27643538
[TBL] [Abstract][Full Text] [Related]
12. Oncohistones in brain tumors: the soil and seed.
Andrade AF; Chen CCL; Jabado N
Trends Cancer; 2023 May; 9(5):444-455. PubMed ID: 36933956
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles for canonical and variant histone H3 lysine-36 in Polycomb silencing.
Salzler HR; Vandadi V; McMichael BD; Brown JC; Boerma SA; Leatham-Jensen MP; Adams KM; Meers MP; Simon JM; Duronio RJ; McKay DJ; Matera AG
Sci Adv; 2023 Mar; 9(9):eadf2451. PubMed ID: 36857457
[TBL] [Abstract][Full Text] [Related]
14. Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.
Wang L; Zhao Z; Ozark PA; Fantini D; Marshall SA; Rendleman EJ; Cozzolino KA; Louis N; He X; Morgan MA; Takahashi YH; Collings CK; Smith ER; Ntziachristos P; Savas JN; Zou L; Hashizume R; Meeks JJ; Shilatifard A
Nat Med; 2018 Jun; 24(6):758-769. PubMed ID: 29785026
[TBL] [Abstract][Full Text] [Related]
15. Histone H3 variants specify modes of chromatin assembly.
Ahmad K; Henikoff S
Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16477-84. PubMed ID: 12177448
[TBL] [Abstract][Full Text] [Related]
16. Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation.
Funato K; Major T; Lewis PW; Allis CD; Tabar V
Science; 2014 Dec; 346(6216):1529-33. PubMed ID: 25525250
[TBL] [Abstract][Full Text] [Related]
17. A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered.
Jackson ER; Persson ML; Fish CJ; Findlay IJ; Mueller S; Nazarian J; Hulleman E; van der Lugt J; Duchatel RJ; Dun MD
Neuro Oncol; 2024 May; 26(Supplement_2):S136-S154. PubMed ID: 37589388
[TBL] [Abstract][Full Text] [Related]
18. Regional identity of human neural stem cells determines oncogenic responses to histone H3.3 mutants.
Bressan RB; Southgate B; Ferguson KM; Blin C; Grant V; Alfazema N; Wills JC; Marques-Torrejon MA; Morrison GM; Ashmore J; Robertson F; Williams CAC; Bradley L; von Kriegsheim A; Anderson RA; Tomlinson SR; Pollard SM
Cell Stem Cell; 2021 May; 28(5):877-893.e9. PubMed ID: 33631116
[TBL] [Abstract][Full Text] [Related]
19. Surprising phenotypic diversity of cancer-associated mutations of Gly 34 in the histone H3 tail.
Lowe BR; Yadav RK; Henry RA; Schreiner P; Matsuda A; Fernandez AG; Finkelstein D; Campbell M; Kallappagoudar S; Jablonowski CM; Andrews AJ; Hiraoka Y; Partridge JF
Elife; 2021 Feb; 10():. PubMed ID: 33522486
[TBL] [Abstract][Full Text] [Related]
20. CHD2 Regulates Neuron-glioma Interactions in Pediatric Glioma.
Zhang X; Duan S; Apostolou PE; Wu X; Watanabe J; Gallitto M; Barron T; Taylor KR; Woo PJ; Hua X; Zhou H; Wei HJ; McQuillan N; Kang KD; Friedman GK; Canoll PD; Chang K; Wu CC; Hashizume R; Vakoc CR; Monje M; McKhann GM; Gogos JA; Zhang Z
Cancer Discov; 2024 May; ():. PubMed ID: 38767413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]